» Articles » PMID: 30581678

Screening of Prognostic Biomarkers for Endometrial Carcinoma Based on a CeRNA Network

Overview
Journal PeerJ
Date 2018 Dec 25
PMID 30581678
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study aims to reveal the regulation network of lncRNAs-miRNAs-mRNA in endometrial carcinoma (EC), to investigate the underlying mechanisms of EC occurrence and progression, to screen prognostic biomarkers.

Methods: RNA-seq and miRNA-seq data of endometrial carcinoma were downloaded from the TCGA database. Edge.R package was used to screen differentially expressed genes. A database was searched to determine differentially expressed lncRNA-miRNA and miRNA-mRNA pairs, to construct the topological network of ceRNA, and to elucidate the key RNAs that are for a prognosis of survival.

Results: We screened out 2632 mRNAs, 1178 lncRNAs and 189 miRNAs that were differentially expressed. The constructed ceRNA network included 97 lncRNAs, 20 miRNAs and 73 mRNAs. Analyzing network genes for associations with prognosies revealed 169 prognosis-associated RNAs, including 92 lncRNAs, 16miRNAs and 61 mRNAs.

Conclusion: Our results reveal new potential mechanisms underlying the carcinogenesis and progression of endometrial carcinoma.

Citing Articles

Advancements in Minimally Invasive Techniques and Biomarkers for the Early Detection of Endometrial Cancer: A Comprehensive Review of Novel Diagnostic Approaches and Clinical Implications.

Asaturova A, Zaretsky A, Rogozhina A, Tregubova A, Badlaeva A J Clin Med. 2025; 13(24.

PMID: 39768459 PMC: 11728107. DOI: 10.3390/jcm13247538.


Mechanism of regulation of KIF23 on endometrial cancer cell growth and apoptosis.

Zhuang R, Liu H Discov Oncol. 2024; 15(1):83.

PMID: 38514510 PMC: 10957832. DOI: 10.1007/s12672-024-00937-x.


CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1.

Zhu X, Yu J, Ai F, Wang Y, Lv W, Yu G Breast Cancer (Dove Med Press). 2024; 15:967-984.

PMID: 38164371 PMC: 10758189. DOI: 10.2147/BCTT.S409054.


The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions.

Thakur L, Thakur S Front Endocrinol (Lausanne). 2023; 14:1166948.

PMID: 37152960 PMC: 10161733. DOI: 10.3389/fendo.2023.1166948.


Establishment of a prognostic-related microRNAs risk model for glioma by bioinformatics analysis.

Wang Y, Zhang C, Lu W, Chen R, Yu M Ann Transl Med. 2021; 9(12):1022.

PMID: 34277822 PMC: 8267265. DOI: 10.21037/atm-21-2402.


References
1.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View

2.
Lewis B, Burge C, Bartel D . Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. DOI: 10.1016/j.cell.2004.12.035. View

3.
Martens J, Nimmrich I, Koenig T, Look M, Harbeck N, Model F . Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. Cancer Res. 2005; 65(10):4101-17. DOI: 10.1158/0008-5472.CAN-05-0064. View

4.
Martianov I, Ramadass A, Serra Barros A, Chow N, Akoulitchev A . Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature. 2007; 445(7128):666-70. DOI: 10.1038/nature05519. View

5.
Vie N, Copois V, Bascoul-Mollevi C, Denis V, Bec N, Robert B . Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Mol Cancer. 2008; 7:14. PMC: 2245978. DOI: 10.1186/1476-4598-7-14. View